Vera Therapeutics Inc (VERA)
42.31
+2.80
(+7.09%)
USD |
NASDAQ |
May 01, 16:00
42.31
0.00 (0.00%)
Pre-Market: 20:00
Vera Therapeutics Free Cash Flow (Quarterly): -25.14M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -25.14M |
| September 30, 2023 | -22.97M |
| June 30, 2023 | -17.77M |
| March 31, 2023 | -26.29M |
| December 31, 2022 | -21.16M |
| September 30, 2022 | -18.46M |
| June 30, 2022 | -19.04M |
| March 31, 2022 | -8.999M |
| Date | Value |
|---|---|
| December 31, 2021 | -6.438M |
| September 30, 2021 | -5.484M |
| June 30, 2021 | -7.665M |
| March 31, 2021 | -4.121M |
| December 31, 2020 | -27.38M |
| September 30, 2020 | -2.447M |
| June 30, 2020 | -2.722M |
| March 31, 2020 | -2.357M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-27.38M
Minimum
Dec 2020
-2.357M
Maximum
Mar 2020
-13.65M
Average
-13.39M
Median
Free Cash Flow (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 118.50M |
| Alpine Immune Sciences Inc | -19.08M |
| Fate Therapeutics Inc | -36.82M |
| Checkpoint Therapeutics Inc | -6.833M |
| Mersana Therapeutics Inc | -32.35M |